Commentary Open Access
Volume 3 | Issue 2 | DOI: https://doi.org/10.33696/cancerimmunol.3.046
Relevance of Neuropilin 1 and Neuropilin 2 Targeting for Cancer Treatment
Aurore Dumond1, Gilles Pagès1,2,*
- 1Scientific Centre of Monaco, Biomedical Department, 8 quai Antoine 1er, MC-98000 Monaco, Principality of Monaco
- 2University Cote D’Azur (UCA), Institute for research on cancer and aging of nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, Nice, France
Corresponding Author
Gilles Pagès, Gilles.Pages@unice.fr
Received Date: March 31, 2021
Accepted Date: April 30, 2021
Dumond A, Pagès G. Relevance of Neuropilin 1 and Neuropilin 2 Targeting for Cancer Treatment. J Cancer Immunol. 2021; 3(2): 111-114.
Copyright: © 2021 Dumond A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Constitutively Active Death Receptor Induces Apoptosis in Mammalian Cells
Apoptosis is a physiological response in development and homeostasis of metazoans. Apoptosis is triggered during pathological events as a means to renew affected tissues and eliminate cancer cells. The immune system regulates the extrinsic pathway of apoptosis, where signals such as TNFα or displayed ligands on the surface of immune cells trigger signal cascades by death receptors present on targeted cells. Therapeutics, like Doxorubicin, lead to apoptosis successfully.
Prevalence of Symptom Clusters in Cancer Patients at First Presentation in Palliative Care Clinic as per Different Disease Groups
Cancer has its own disease burden and patients usually suffer from symptom clusters when they are referred for palliative treatment. Identification of symptom cluster trajectories will help clinician to take into account measures that can optimize quality of life of palliative patients. Therefore the aim of this paper is to determine the overall prevalence of symptoms and symptoms clusters in different disease groups according to etiology at the time of first visit to Palliative care clinic by using HIS Palliative First Assessment note indicating Edmonton symptom scale.
Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer
Although NK cells are recognized as effector lymphocytes of the innate immune system, they also regulate the adaptive immune response by releasing inflammatory cytokines and developing immunological memory. Unlike other lymphocytes such as T or B cells, NK cells do not express rearrangeable, antigen-specific receptors.
Emerging Role of TRPML1 Mucolipin Endolysosomal Channel in Cancer
The transient receptor potential mucolipin 1 (TRPML1) is an endolysosomal channel belonging to the TRP family. Clinically, mutations of TRPML1 have been responsible for a severe lysosomal storage disorder called mucolipidosis type IV.
Uniportal VATS Lobectomy for Lung Cancer: Feasibility and Cost Effectiveness in a Single Center Experience
In last decades, video-assisted thoracic surgery (VATS) together with robotic-assisted thoracic surgery (RATS) can be considered the biggest innovation in thoracic surgery. This approach drastically changed the way of performing surgical operations, improving patient’s outcome undergoing thoracic surgery.